FDA posted a shortage of the immediate release formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall or Adderall IR.| U.S. Food and Drug Administration
FDA approves multiple generics of ADHD and BED treatment| U.S. Food and Drug Administration